Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKesson
Moodys
Dow
Harvard Business School
Daiichi Sankyo
Merck
Baxter
Federal Trade Commission
AstraZeneca

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088441

« Back to Dashboard

NDA 088441 describes URECHOLINE, which is a drug marketed by Odyssey Pharms and is included in five NDAs. It is available from two suppliers. Additional details are available on the URECHOLINE profile page.

The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
Summary for 088441
Tradename:URECHOLINE
Applicant:Odyssey Pharms
Ingredient:bethanechol chloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 088441
Medical Subject Heading (MeSH) Categories for 088441
Suppliers and Packaging for NDA: 088441
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
URECHOLINE bethanechol chloride TABLET;ORAL 088441 ANDA Teva Pharmaceuticals USA, Inc. 50111-325 50111-325-01 100 TABLET in 1 BOTTLE (50111-325-01)
URECHOLINE bethanechol chloride TABLET;ORAL 088441 ANDA Teva Women's Health, Inc. 51285-691 51285-691-02 100 TABLET in 1 BOTTLE (51285-691-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:May 29, 1984TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
Queensland Health
Merck
Citi
Healthtrust
McKesson
Chubb
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot